Evidence map›Paper›PMID 35580655›Full record

ArticleGastroenterology2022

Impact of the COVID-19 Pandemic on Fecal Immunochemical Testing, Colonoscopy Services, and Colorectal Neoplasia Detection in a Large United States Community-based Population.

Jeffrey K Lee, Angela Y Lam, Christopher D Jensen, Amy R Marks, Jessica Badalov, Evan Layefsky, Kevin Kao, Ngoc J Ho, Joanne E Schottinger, Nirupa R Ghai and 6 more

Open access · greenAbstract read
In one paragraph

Article in Gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Jeffrey K LeeDepartment of Gastroenterology, Kaiser Permanente San Francisco Medical Center, San Francisco, California; Division of Research, Kaiser Permanente Northern California, Oakland, California. Electronic address: Jeffrey.K.Lee@kp.org.
Angela Y LamDepartment of Gastroenterology, Kaiser Permanente San Francisco Medical Center, San Francisco, California.
Christopher D JensenDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Amy R MarksDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Jessica BadalovDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Evan LayefskyDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Kevin KaoDepartment of Gastroenterology, Kaiser Permanente Downey Medical Center, Downey, California; Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California.
Ngoc J HoResearch and Evaluation, Kaiser Permanente Southern California, Pasadena, California.
Joanne E SchottingerKaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California.
Nirupa R GhaiDepartment of Quality and Systems of Care, Kaiser Permanente Southern California, Pasadena, California.
Cheryl M CarlsonResearch and Evaluation, Kaiser Permanente Southern California, Pasadena, California.
Ethan A HalmDepartment of Population and Data Sciences and the Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
Beverly GreenKaiser Permanente Washington Health Research Institute, Seattle, Washington.
Dan LiDivision of Research, Kaiser Permanente Northern California, Oakland, California; Department of Gastroenterology, Kaiser Permanente Santa Clara Medical Center, Santa Clara, California.
Douglas A CorleyDepartment of Gastroenterology, Kaiser Permanente San Francisco Medical Center, San Francisco, California; Division of Research, Kaiser Permanente Northern California, Oakland, California.
Theodore R LevinDivision of Research, Kaiser Permanente Northern California, Oakland, California; Department of Gastroenterology, Kaiser Permanente Walnut Creek Medical Center, Walnut Creek, California.
Kaiser Permanente · USKaiser Permanente San Francisco Medical Center · USKaiser Permanente Washington Health Research Institute · USThe University of Texas Southwestern Medical Center · US

Funding

Optimizing Colorectal Cancer Screening PREcision and Outcomes in CommunIty-baSEd Populations (PRECISE)UM1CA222035 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI CHUBAK, JESSICA, CORLEY, DOUGLAS ALLEN · 2018 to 2023
$15.6M
Optimizing long-term post-polypectomy surveillance for colorectal cancer prevention using a prediction rule developed from a large, community-based cohortK07CA212057 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LEE, JEFFREY KUANG ZOU · 2016 to 2020
$869k
NCI NIH HHS K07 CA212057NCI NIH HHS UM1 CA222035
6 · The paper itself

Abstract

BACKGROUND &

aimsThe COVID-19 pandemic has affected clinical services globally, including colorectal cancer (CRC) screening and diagnostic testing. We investigated the pandemic's impact on fecal immunochemical test (FIT) screening, colonoscopy utilization, and colorectal neoplasia detection across 21 medical centers in a large integrated health care organization.

methodsWe performed a retrospective cohort study in Kaiser Permanente Northern California patients ages 18 to 89 years in 2019 and 2020 and measured changes in the numbers of mailed, completed, and positive FITs; colonoscopies; and cases of colorectal neoplasia detected by colonoscopy in 2020 vs 2019.

resultsFIT kit mailings ceased in mid-March through April 2020 but then rebounded and there was an 8.7% increase in kits mailed compared with 2019. With the later mailing of FIT kits, there were 9.0% fewer FITs completed and 10.1% fewer positive tests in 2020 vs 2019. Colonoscopy volumes declined 79.4% in April 2020 compared with April 2019 but recovered to near pre-pandemic volumes in September through December, resulting in a 26.9% decline in total colonoscopies performed in 2020. The number of patients diagnosed by colonoscopy with CRC and advanced adenoma declined by 8.7% and 26.9%, respectively, in 2020 vs 2019.

conclusionsThe pandemic led to fewer FIT screenings and colonoscopies in 2020 vs 2019; however, after the lifting of shelter-in-place orders, FIT screenings exceeded, and colonoscopy volumes nearly reached numbers from those same months in 2019. Overall, there was an 8.7% reduction in CRC cases diagnosed by colonoscopy in 2020. These data may help inform the development of strategies for CRC screening and diagnostic testing during future national emergencies.

Indexed as

Colorectal NeoplasmsCOVID-19AdolescentAdultAgedAged, 80 and overColonoscopyCommunity Health ServicesEarly Detection of CancerFecesHumansMass ScreeningMiddle AgedOccult BloodPandemicsRetrospective StudiesCancerColonoscopyCOVID-19PandemicScreening

Identifiers

PMID35580655
PMCPMC9107101
OpenAlexW4280614437

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.